No Vaccine
We are all hoping for a vaccine in 2021. But what do we do in the meantime? And more importantly, what if no vaccine emerges?
Humanity will have to live with the threat of coronavirus “for the foreseeable future” and adapt accordingly because there is no guarantee that a vaccine can be successfully developed, one of the world’s leading experts on the disease has warned.
The stark message was delivered by David Nabarro, professor of global health at Imperial College, London, and an envoy for the World Health Organisation on Covid-19, as the number of hospital deaths from the virus passed 250,000.
Hopes for a return to normal life after the coronavirus hinge on the development of a vaccine. But there’s no guarantee, experts say, that a fully effective COVID-19 vaccine is possible.
Remember Dengvaxia in the Philippines?
In a worse-case scenario, a phenomenon called “immune enhancement” can cause vaccines to make the symptoms of infections worse. Instead of preventing the virus from entering healthy cells, the antibodies actually help them to do so. In 2016, after some 800,000 Filipino schoolchildren were given a dengue-fever vaccine called Dengvaxia, officials realized that some of them had been put at increased risk of life-threatening complications. Investigators wound up looking into the deaths of some 600 children who’d taken part.
Back during the SARS outbreak, researchers were unable to test their SARS vaccine candidates for effectiveness in humans. To do so, they would have had to inoculate a population that was exposed to SARS, and the disease was effectively wiped out using public-health measures before that could happen.
Remember HIV… well that didn’t work
In 1984, the US Secretary of Health and Human Services announced that scientists had successfully identified the virus that later became known as HIV — and predicted that a preventative vaccine would be ready for testing in two years.
Nearly four decades and 32 million deaths later, the world is still waiting for an HIV vaccine.
For many years, a positive diagnosis was not only a death sentence; it ensured a person would spend their final months abandoned by their communities, while doctors debated in medical journals whether HIV patients were even worth saving.
In 1997, President Bill Clinton challenged the US to come up with a vaccine within a decade… that was fourteen years ago.
The difficulties in finding a vaccine began with the very nature of HIV/AIDS itself.
Outbreak Every Year
Treatments may be developed — but outbreaks of the disease could still occur each year, and the global death toll would continue to tick upwards.
It’s a path rarely publicly countenanced by politicians, who are speaking optimistically about human trials already underway to find a vaccine.
But the possibility is taken very seriously by many experts — because it’s happened before. Several times.
“There are some viruses that we still do not have vaccines against,” says Dr. David Nabarro.
“We can’t make an absolute assumption that a vaccine will appear at all, or if it does appear, whether it will pass all the tests of efficacy and safety.
“It’s absolutely essential that all societies everywhere get themselves into a position where they are able to defend against the coronavirus as a constant threat, and to be able to go about social life and economic activity with the virus in our midst,” Nabarro tells CNN.
Not Achievable
But even if a vaccine is developed, bringing it to fruition in any of those timeframes would be a feat never achieved before.
“We’ve never accelerated a vaccine in a year to 18 months,” Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine in Houston, tells CNN.
“It doesn’t mean it’s impossible, but it will be quite a heroic achievement.
“We need plan A, and a plan B,” he says.
What’s Our Plan B?
We all hope the massive global effort to develop a vaccine or drug treatment for COVID-19 is successful. But many experts, including Ian Frazer, who developed Australia’s HPV vaccine, think it will not be easy or quick.
If an effective vaccine or drug doesn’t materialise, we will need a Plan B that uses only non-drug interventions.
That’s why we need high-quality research to find out which ones work and how to do them as effectively as possible.
To prepare for the future and Plan B, the case where a vaccine doesn’t arrive, we need to conduct randomised trials into non-drug interventions to prevent the spread of respiratory viruses.
The current pandemic is presenting us with a rare opportunity to rapidly conduct trials to answer many of the unknowns about this set of non-drug interventions.
Concentrating all our funding, efforts, and resources into vaccine and drug research may turn out to be a devastating and costly mistake in both healthcare and economic terms. The results will be felt not only in this pandemic, but also in future ones.
If the same fate befalls a COVID-19 vaccine, the virus could remain with us for many years. But the medical response to HIV/AIDS still provides a framework for living with a disease we can’t stamp out.
“In HIV, we’ve been able to make that a chronic disease with antivirals. We’ve done what we’ve always hoped to do with cancer,” Offit says. “It’s not the death sentence it was in the 1980s.”
The groundbreaking development of a daily preventative pill — pre-exposure prophylaxis, or PrEP — has since led to hundreds of thousands of people at risk of contracting HIV being protected from the disease.
A number of treatments are likewise being tested for COVID-19, as scientists hunt for a Plan B in parallel to the ongoing vaccine trials, but all of those trials are in very early stages.
How the world looks like without a vaccine?
If a vaccine can’t be produced, life will not remain as it is now. It just might not go back to normal quickly.
“The lockdown is not sustainable economically, and possibly not politically,” says Neal. “So we need other things to control it.”
That means that, as countries start to creep out of their paralyses, experts would push governments to implement an awkward new way of living and interacting to buy the world time in the months, years or decades until COVID-19 can be eliminated by a vaccine.
“It is absolutely essential to work on being COVID-ready,” Nabarro says.
What Can We Do Now?
There’s no guarantee a coronavirus vaccine will arrive, so we need research to understand the best ways to use facemasks, hand hygiene, and other interventions to control the spread of the disease.
We are being saved by non-drug interventions such as quarantine, social distancing, handwashing, and – for health-care workers – masks and other protective equipment.
Other COVID-19 Updates
COVID-19: SOCIAL IMPACT
GineersNow Distributes PPE to Medical Workers
Israeli Cured COVID-19 Patients Using Placenta
COVID-19: HARVARD BUSINESS SCHOOL
Harvard Talks: Engineering Sector’s Organizational Development
Harvard Talks: Engineering Leaders Will Engage in Teaming
Harvard Covid-19 Strategy on How to Reopen a Country
Harvard Talks: Forward-Thinking Engineering Leaders
Harvard Talks: Engineering Operation Impact of COVID-19
Harvard Talks: 7 Leadership Principles in the Time of COVID-19
Harvard Talks: Engineering Work Culture After COVID-19 Pandemic
Harvard Talks: 7 Leadership Principles in the Time of COVID-19
Harvard Talks: Cut Salaries or Cut People?
Harvard Talks: The Supply Chain in Post COVID-19 Era
COVID-19: WORLD HEALTH ORGANIZATION
WHO Preparedness and Response to COVID-19
WHO Q&A: COVID-19 and Influenza Comparison
COVID-19: CONSTRUCTION
Construction Force Majeure During COVID-19
Converting Existing Building to COVID-19 Hospital – WHO Guidelines
WHO COVID-19 Buildings & Tents Screening Layout Standards
COVID-19: HVAC
COVID-19 Hotel is a Huge HVAC Nightmare
Ventilation Standards for Buildings Converted to COVID-19 Hospitals
Air Filtration for COVID-19 Treatment Centers
ASHRAE on COVID-19 HVAC Concerns
COVID-19: ENERGY
Oil Price Crashes Below $0 per Barrel
Coronavirus will accelerate the growth of renewable energy solutions
COVID-19: ECONOMIC IMPACT
COVID-19 Economic Impact Analysis
COVID-19 Economic Aftermath on the Construction Industry
Postponed Exhibitions in the Philippines due to COVID-19
Cancelled Major Events Around the World Due to COVID-19
World Bank Gives $12 Billion to COVID-19 Affected Countries
COVID-19: VENTILATORS & PPE
UCLA Biodesign Fellow Focuses Biomedical Engineering Insights on Swabs Shortage
Philips Ventilator Respironics E30 for ICU COVID-19 Patients
Here’s the Tesla Ventilator Prototype
Lamborghini Medical Shields & Surgical Masks for Health Workers
UCLA Engineer Made a Ventilator from Hardware Items
Forecast Deaths, Hospitals & Ventilators: COVID-19 Impact, USA Full Report
Top 10 Largest Ventilator Manufacturers in the World
Metronic Ventilator Ramping Up Production
Engineers, Can You Help Build a DIY Ventilator for Hospitals?
PPE Shortage Endangering Health Workers Worldwide
COVID-19: STATISTICS & FORECASTS
COVID-19 Deaths to Reach 81,000 in US By June – Forecasts by IHME & Univ. of Washington
List of Government Officials Tested Positive in PH
COVID-19 War: 70K Physicians vs 109M Filipinos
Famous People Who Have Tested Positive for COVID-19
These Politicians Tested Positive for Coronavirus (COVID-19)
COVID-19 Philippines: DOH on Code Red Status
COVID-19: SCIENCE
100% Success Rate for Pluristem COVID-19 Treatment
What If There’s No Vaccine To Fight COVID-19?
COVID-19 Treatment: The Search Continues
Clean Air in Europe leads to 11K Fewer Deaths During Lockdown
Complete List of Companies Working on Coronavirus Vaccine
Tiger Tests Positive for Coronavirus at New York Zoo
COVID:19: PREVENTION TIPS
We Need Testing, Vaccine & Treatment, But Until That Happens, We Need This!
How to Create a COVID-19 Proof Workplace
Work From Home Tips for Engineering, Industrial & Tech Companies
Water is Our First Line of Defense Against COVID-19
The List of COVID-19 Disinfectants Approved by EPA
COVID-19: TECHNOLOGY
Robot Technology to Reinstate a COVID-Free Airport
How Artificial Intelligence Can Drive Greater Speed and Accuracy in Vaccine Development
Cyber-Criminals are Exploiting People’s Fears of COVID-19
COVID-19: MARKETING
How to Apply for Government Financial Assistance for SMEs
Harvard Talks: How Marketing Works During COVID-19
Rewriting Marketing in Times of COVID-19 Crisis?
Hyundai Motor Extends Warranties Due to COVID-19
Top 5 Most Traded Stocks During COVID-19
COVID-19: EDUCATION
Coaching Builds COVID-19 Resilience to Engineering Team
How COVID-19 Is Changing College Admissions Cycle in 2020
COVID-19: AVIATION
Can We Give Airline Financial Relief to Protect Their Jobs?
Airlines Around the World are Struggling to Survive
COVID-19: APAC Air Passenger Demand Dropped 65.5%
Emirates Airline Passenger Rules During COVID-19
Airlines Around the World are Struggling to Survive
Show Your COVID-19 Test Result at the Airport
The Most Modern Flying Hospital with ICU from Germany
COVID-19 Impact: 25 Million Jobs at Risk with Airline Shutdown
Airbus Gives 3D-Printed Hospital Visors to Health Workers
Airlines COVID-19 Analysis: Aviation Collapsed
Air Cargo Demand Down 3.3% due to COVID-19 Disruption
COVID-19 Financial Impacts in the Aviation Industry
COVID-19 Hits January Airline Passenger Demand, IATA